• December 1, 2024 – Appellate Decision Still Pending

    Published On: January 2, 2025|Categories: Tylenol|By |

    As we await the appellate court’s decision on the dismissal of the Tylenol and autism MDL, new claims continue to be filed in state courts nationwide. If your child has been diagnosed with autism, you may still have legal avenues to pursue compensation. The Lawsuit Legal News team is here to provide answers, helping you understand whether you can file a claim in state court or if you qualify for a toxic baby food autism lawsuit against certain baby food manufacturers. Let us guide you through your options.

  • November 1, 2024 – MDL Plaintiffs Appeal Judge’s Dismissal

    Published On: January 2, 2025|Categories: Tylenol|By |

    The appeal challenging the dismissal of the Tylenol autism and ADHD MDL is now underway. Plaintiffs argue that Judge Cote improperly excluded expert testimony linking Tylenol use during pregnancy to developmental disorders in children. The appeal claims the judge misapplied the Daubert standard, which ensures evidence is based on sound scientific principles, and wrongly took on the role of a scientist in deciding the medical dispute. The plaintiffs contend that the judge’s focus on public policy rather than scientific methods was inappropriate for the Daubert hearing.

    As appeals take time, a ruling is not expected until early next year. We will provide updates as more information becomes available.

  • October 1, 2024 – Tylenol Lawsuits Continue in State Courts

    Published On: January 2, 2025|Categories: Tylenol|By |

    After the dismissal of the federal MDL in August, plaintiffs’ lawyers have turned to appeal as their last option. We will provide updates on the appellate filing as soon as new details emerge. Meanwhile, several state-level cases are still ongoing, particularly in Illinois and California. In these cases, Johnson & Johnson has filed motions to dismiss based on federal preemption. We will continue to update this page as those rulings are issued. The California case is scheduled for trial in April 2025.

  • September 1, 2024 – Judge Cote Dismisses Federal Multidistrict Litigation

    Published On: January 2, 2025|Categories: Tylenol|By |

    On August 20, 2024, Judge Cote officially dismissed all cases in the Tylenol Autism Multidistrict Litigation, following her July ruling. Plaintiffs’ counsel has filed an appeal, but if the appeal is unsuccessful, all federal cases will be considered resolved in favor of the defendant drug manufacturers.